Clinical Trial Update: Trial of Amitriptyline for Chronic Oral Food Refusal in Children 9 Months to 8 Years of Age [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating amitriptyline for chronic oral food refusal in children aged 9 months to 8 years. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Food Refusal

Drugs mentioned

• amitriptyline (amitriptyline)

Snippet

Sponsor: Ann Davis, PhD, MPH, ABPP | Conditions: Chronic Oral Food Refusal | Phase 2 | Status: COMPLETED | Results posted: 2016-08-15